Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders

An emerging role for eotaxins in neurodegenerative disease

(2018) Amanda K. Huber et al.   CLINICAL IMMUNOLOGY

Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy

(2018) Hsiang-Wei Kuo et al.   DRUG AND ALCOHOL DEPENDENCE

Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis

(2017) S P Leighton et al.   MOLECULAR PSYCHIATRY

Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls

(2017) Pei-Shen Ho et al.   PSYCHIATRY RESEARCH

Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging

(2017) Leticia Sanguinetti Czepielewski et al.   SCHIZOPHRENIA BULLETIN

Abnormalities in chemokine levels in schizophrenia and their clinical correlates

(2017) Suzi Hong et al.   SCHIZOPHRENIA RESEARCH

Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity

(2017) Nuria García-Marchena et al.   Frontiers in Psychiatry

The Immunology of Bipolar Disorder

(2017) Izabela Guimarães Barbosa et al.   NEUROIMMUNOMODULATION

Update on bipolar disorder biomarker candidates

(2016) Antonio L. Teixeira et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

(2016) D R Goldsmith et al.   MOLECULAR PSYCHIATRY

Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder

(2016) Damla Tokac et al.   Psychiatry Investigation

Reductions in eosinophil biomarkers by benralizumab in patients with asthma

(2016) Tuyet-Hang Pham et al.   RESPIRATORY MEDICINE

Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample

(2015) G. R. Cunha et al.   ACTA PSYCHIATRICA SCANDINAVICA

CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia

(2015) Bijay Parajuli et al.   GLIA

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

(2015) B. Panizzutti et al.   JOURNAL OF AFFECTIVE DISORDERS

Evidence for the contribution of adult neurogenesis and hippocampal cell death in experimental cerebral malaria cognitive outcome

(2015) A.S. de Miranda et al.   NEUROSCIENCE

High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance

(2015) Cristiano Noto et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders

(2015) Michael J. Stuart et al.   Frontiers in Cellular Neuroscience

Eotaxin-1 (CCL11)

(2015) Timothy John Williams   Frontiers in Immunology

The effects of an epithelial barrier protective cationic aerosol on allergen-induced airway inflammation in asthma: a randomized, placebo-controlled clinical trial

(2014) P. Nair et al.   CLINICAL AND EXPERIMENTAL ALLERGY

CCL11 as a potential diagnostic marker for asthma?

(2014) Dandan Wu et al.   JOURNAL OF ASTHMA

Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis

(2014) A Masi et al.   MOLECULAR PSYCHIATRY

Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies

(2014) M.J. Stuart et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: A clue for understanding accelerating aging profile

(2014) Mariana Pedrini et al.   SCHIZOPHRENIA RESEARCH

Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder

(2013) Lucas Bortolotto Rizzo et al.   BIPOLAR DISORDERS

Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial

(2013) H. Neighbour et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia

(2013) Elson Asevedo et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults

(2013) Pedro V.S. Magalhaes et al.   JOURNAL OF PSYCHIATRIC RESEARCH

CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging

(2013) K. Baruch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A cytokine study of adult patients with obsessive-compulsive disorder

(2012) Leonardo F Fontenelle et al.   COMPREHENSIVE PSYCHIATRY

The Chemokine Superfamily Revisited

(2012) Albert Zlotnik et al.   IMMUNITY

Peripheral chemokine levels in women with recurrent major depression with suicidal ideation

(2012) Rodrigo Grassi-Oliveira et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

The ageing systemic milieu negatively regulates neurogenesis and cognitive function

(2011) Saul A. Villeda et al.   NATURE

Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder

(2009) Elisa Brietzke et al.   BRAIN BEHAVIOR AND IMMUNITY

Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology

(2009) Richard M. Ransohoff   IMMUNITY

A detailed examination of cytokine abnormalities in Major Depressive Disorder

(2007) N.M. Simon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Increased serum levels of CCL11/eotaxin in schizophrenia

(2007) Antonio Lucio Teixeira et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY